Reported Apr 1, 2024 · Announced
AvKARE, LLC recalls AVpak Atovaquone Oral Suspension, USP 750mg/5mL due to Potential Bacillus cereus contamination
AvKARE, LLC
Risk not classifiedThe agency has not ranked the risk yet — treat the notice as a caution.What you should do
Stop using the product and follow the return or refund instructions in the firm's announcement.
Is this the product you have?
- Atovaquone Oral Suspension
- USP 750mg/5mL BrandAVpak. Drugs
Why it was recalled
Potential Bacillus cereus contamination
The agency has not ranked the risk yet — treat the notice as a caution.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new AvKARE, LLC recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.